IBRX
NASDAQ · Biotechnology
Immunitybio Inc
$8.55
+0.54 (+6.74%)
Performance
1D
-0.98%
1W
+7.55%
1M
-13.72%
3M
+14.15%
6M
+5.43%
1Y
+301.41%
YTD
+323.27%
Open$8.15
Previous Close$8.01
Day High$8.58
Day Low$7.88
52W High$12.43
52W Low$1.95
Volume—
Avg Volume8.83M
Market Cap8.69B
P/E Ratio—
EPS$-0.97
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$8.74
Below
SMA 200
$7.96
Above
RSI (14)
51.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,172.4% upside
Current
$8.55
$8.55
Target
$108.79
$108.79
$71.54
$108.79 avg
$142.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 125.15M | 1.55B | 1.61B |
| Net Income | -388,047,573 | 174.18M | 206.87M |
| Profit Margin | -310.2% | 11.2% | 12.9% |
| EBITDA | -265,639,896 | 310.76M | 319.11M |
| Free Cash Flow | — | 125.72M | 219.44M |
| Rev Growth | +678.6% | +14.4% | +15.1% |
| Debt/Equity | 0.01 | 0.68 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |